Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

The Portico FDA investigational device exemption (IDE) study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems. #TAVR #TCT2019
News | Heart Valve Technology | October 02, 2019
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one-...
Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital.

Khaldoon Alaswad, M.D., right, director, cardiac catheterization lab, during a complex CTO procedure at Henry Ford Hospital. (Photo by Dave Fornell)

Feature | Henry Ford Hospital | October 01, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology...
This shows the TEE ultrasound imaging used to guide MitraClip procedures to treat functional mitral regurgitation.
360 Photos | 360 View Photos | October 02, 2019
This 360 degree view shows staff at the University of Colorado Heart and Vascular Center performing live...
Videos | Cardiovascular Business | September 30, 2019
A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman...
Videos | Heart Valve Technology | September 30, 2019
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of...
Videos | Structural Heart | September 30, 2019
A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice...
Medtronic Launches Evolut Pro+ TAVR System
Technology | Heart Valve Technology | September 24, 2019
September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Evolut...
Abbott Receives European CE Mark for Two Pediatric Heart Devices
News | Congenital Heart | September 20, 2019
September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm...
New Research on Tempo Temporary Pacing Lead to Be Featured at TCT 2019
News | Leads Implantable Devices | September 20, 2019
September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter...
Reducing Secondary Mitral Regurgitation in Heart Failure Does Not Improve Two-year Outcomes
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not...
Abbott Launches Pivotal Trial of TriClip Tricuspid Valve Repair System
News | Heart Valve Technology | September 05, 2019
September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and...
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.

The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology. 

Feature | September 03, 2019 | Dave Fornell, Editor
September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...
An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire

An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire is electrified to lacerate the leaflet, and the the leaflet splays after TAVR permitting coronary flow.

Feature | Heart Valve Technology | August 27, 2019
A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve...
Advice for Hospitals Starting A Structural Heart Program With John Carroll, M.D.
Podcast | Structural Heart | August 23, 2019
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the...
Edwards Recalls Sapien 3 Ultra Delivery System Due to Burst Balloons During Surgery
News | Heart Valve Technology | August 22, 2019
August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst...